Objective
We aimed to describe the genomic and clinical characteristics of the no specific molecular profile (NSMP: POLE-WT, MSS, and TP53-WT) endometrial cancer (EC) tumor cohort and to clarify the utility of estrogen receptor (ER) status.
– Caris Life Sciences
Objective
We aimed to describe the genomic and clinical characteristics of the no specific molecular profile (NSMP: POLE-WT, MSS, and TP53-WT) endometrial cancer (EC) tumor cohort and to clarify the utility of estrogen receptor (ER) status.